STAT3 and neoplasm: It was reported that nearly 60% of clinical HCC tumor samples showed nuclear phosphorylated-STAT3 staining [154], suggesting that targeting STAT3 signaling pathway may be an effective treatment for HCC with constitutively or inductively active STAT3.